Redoxis is pleased to announce that our Chief Business Officer, Nina Woodworth, will be attending Nordic Life Science Days (NLSDays) 2026 in Stockholm.
NLSDays is one of the leading partnering events in the Nordic life science community, bringing together biotech and pharmaceutical companies, investors, service providers, and research organizations from across Europe and beyond. The meeting provides an excellent opportunity to discuss new collaborations, emerging technologies, and the evolving needs of the life science industry.
Nina will be meeting with both existing and prospective partners to discuss how Redoxis supports drug development through high-quality preclinical research. With expertise spanning inflammation, autoimmune diseases, neuroinflammation, and advanced therapeutic modalities, Redoxis works closely with biotech and pharmaceutical companies to generate robust, decision-enabling data tailored to each program.
If you are attending NLSDays and would like to learn more about our preclinical capabilities or discuss a potential collaboration, Nina would be delighted to connect.
We look forward to meeting you in Stockholm!